Ministry of Science and Technology: One patient who received the recovery period plasma treatment has been discharged from the hospital

On February 17, the Joint Defense and Control Mechanism of the State Council held a press conference on the theme of new coronavirus infection pneumonia in Beijing to introduce the progress of medical treatment. Sun Yanrong, deputy director of the Biological Center of the Ministry of Science and Technology, and Guo Yanhong, Inspector of the Medical and Health Hospital of the National Health and Health Commission, explained the “progress of plasma treatment during recovery period”.

Sun Yanrong said that recovery plasma treatment is one of the ancient and innovative first aid measures, in the last ten years of sudden infectious diseases have been applied. In the first batch of scientific research emergency projects set up by the scientific research team on January 22nd, the preparation of plasma during the recovery period was incorporated into the project support.

Ministry of Science and Technology: One patient who received the recovery period plasma treatment has been discharged from the hospital

Sun Yanrong pictured according to CCTV News

China Bio is the Ministry of Science and Technology emergency special commitment unit, China Bio undertakes science and technology emergency special, emergency deployment in Wuhan, on February 1 to collect the first recovery patient plasma, February 9, the first seriously ill patients in Wuhan Jiangxia District First People’s Hospital received treatment. Over the next week, 10 patients were treated.

‘As far as we know, one of the patients being treated has been discharged from the hospital, one has been able to walk down, and the remaining patients are in the recovery period, we will also pay close attention to clinical progress, ‘ Sun said. The scientific research team will also carry out the expected efficacy and risk assessment of the plasma treatment methods during the recovery period, and we will follow up and study in a timely manner.

Sun Yanrong said that for intensive treatment, clinical research shows that the recovery period plasma has a safety and a certain effect, this is a system engineering affecting the whole society, the need for the government, hospitals, enterprises, medical personnel, rehabilitation people to work together to be able to play in a short period of time to treat seriously ill patients the greatest effect. The Ministry of Science and Technology will also work with the Health and Health Commission to promote this work in clinical application.

“Here, I would like to take this opportunity to thank the first woman to donate 300 ml of plasma, and we sincerely thank all those who have donated the plasma, because their efforts provide a powerful weapon for the clinical treatment of critical patients, and because of their efforts, they have given new hope to the patients who are struggling on the lifeline.” Guo Yanhong said that there are more than 10,000 people cured, but there are still more than 10,000 seriously ill patients, and that has been cured more than 10,000 people are their hope. Here we call, can be in the whole society to carry out “thousands of people to save thousands of people” action, hoping that more rehabilitation people out stretched out their arms, donated plasma, can let love relay, let life continue, as long as the whole society work together, will be able to overcome the epidemic.

Ministry of Science and Technology: One patient who received the recovery period plasma treatment has been discharged from the hospital

The scene of the press conference is pictured according to CCTV News

Guo Yanhong also introduced that the recovery period plasma treatment is a very effective important means of serious illness and critical illness. For the recovery period plasma, from its collection, preparation, storage to clinical applications have strict quality control requirements, at the same time we guide the establishment of provincial expert groups to restore the collection of plasma and patient treatment work for the whole process of quality control, not only to protect the health of blood donors, but also to ensure the safety of seriously ill and critically ill patients.

“I also call for a cure for discharged patients who can donate their plasma, giving hope to critically ill and critically ill patients, ” Guo said. “